Gimel Health expands personalized psychiatric care in New Jersey and New York

By AI, Created 10:34 AM UTC, May 20, 2026, /AGP/ – Gimel Health says it is expanding access to personalized psychiatric evaluation and medication management for patients in New Jersey and the New York metropolitan area. The Fort Lee clinic is positioning its care model around molecular and cellular biology to guide diagnosis, medication selection, and follow-up for complex mental health conditions.

Why it matters: - Gimel Health is targeting patients who have not improved with standard psychiatric treatment. - The clinic says its biology-based approach is designed to improve diagnosis and medication decisions for complex mental health conditions. - Patients in New Jersey and New York now have another outpatient option for individualized psychiatric care and medication management.

What happened: - Gimel Health, a psychiatric clinic based in Fort Lee, New Jersey, is expanding personalized psychiatric evaluation and medication management services across New Jersey and the New York metropolitan area. - The clinic says its practice is grounded in molecular and cellular biology. - Clinic leadership says the model is built to treat mental health conditions at a biological level, not only through symptom management.

The details: - Gimel Health evaluates patients using symptom profiles, medical history, and prior response patterns to build individualized treatment plans. - Psychiatric evaluations at Gimel Health go beyond symptom checklists and examine biological factors that may be driving a patient’s condition. - Medication decisions are based on biological rationale, with plans that can include medication initiation, dosage adjustments, and ongoing monitoring. - Patients are seen regularly, and treatment is refined as clinical progress changes. - The clinic says latest research informs medication selection and treatment timelines are adjusted based on patient progress rather than a fixed schedule. - Gimel Health provides outpatient psychiatric care for generalized anxiety disorder, panic disorder, major depressive disorder, treatment-resistant depression, bipolar disorder, ADHD, OCD, sleep disorders, eating disorders, and complex mood disorders.

Between the lines: - The clinic is leaning into a broader shift in psychiatry toward more biologically targeted treatment. - Demand for psychiatric specialty care is rising while access to qualified providers has not kept pace. - Patients with treatment-resistant depression, complex mood disorders, and co-occurring conditions are often underserved by primary care. - Clinic Director Michael Feldman said his background in molecular and cellular biology shapes how he evaluates patients and selects medications. - “Psychiatric conditions have biological roots,” Feldman said. “When you understand the underlying pathways, you make better clinical decisions.”

What’s next: - Gimel Health is likely to keep focusing on individualized care for patients who need more specialized psychiatric support. - The clinic says patients are increasingly seeking private practices that offer direct access, longer appointments, and biologically grounded treatment plans. - Gimel Health continues to serve patients across New Jersey and the New York metropolitan area.

The bottom line: - Gimel Health is betting that precision psychiatry and deeper biological assessment can improve care for patients with difficult-to-treat mental health conditions.